News-Medical.Net on MSN
One‑Step ADC Manufacturing Reaches 95% Yield in Under One Hour, BioDlink White Paper Reveals
A new white paper from BioDlink, From Complexity to Consistency: How CDMOs Can Unlock One-Step, High-Yield and Homogeneous ...
In a short time, the satellite-to-mobile service has reached an unprecedented number of customers with life-saving ...
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
Vietnam Investment Review on MSN
Kelun Biotech presents strategy at JPM conference
From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmaceutical ...
20h
Medicenna Therapeutics Corp.: Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, ...
The NEO-CYT study, sponsored by Fondazione Melanoma Onlus, will be evaluating MDNA11 in front-line therapy for resectable advanced cutaneous melanoma with patient enrolment planned to commence in H1 ...
Scientists have transformed enigmatic cell structures, called vaults, into storage units for messenger-RNA molecules made in ...
AstraZeneca is relying on several upcoming products to help hit its target of $80 billion in revenue by 2030, including drugs ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback